2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$2.01-$0.04 (-1.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $121.1MMarket Cap
- -49.13%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$2.01-$0.04 (-1.72%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.04 | ||
Change | +$0.03 (+1.49%) | ||
Open | $2.02 | ||
High | $2.10 | ||
Low | $1.99 | ||
Previous Close | $2.01 | ||
Volume | 819,374 | ||
30-Day Average Volume | 1,340,727 | ||
1-Week Change | 10.27% | ||
1-Month Change | -50.84% | ||
1-Year Change | -49.13% | ||
3-Year Change | -30.61% | ||
5-Year Change | -83.54% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $203.4M | ||
Market Cap | $121.1M | ||
Enterprise Value | $53.1M | ||
Period: QTR TTM FY | |||
Revenue | $16.1M | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$17.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $119.5M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 3 | ||
P/B | -1 | ||
P/E | -20 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue